{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:42:48Z","timestamp":1789684968571,"version":"4.0.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,4,25]],"date-time":"2010-04-25T00:00:00Z","timestamp":1272153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s00115-010-2996-6","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T13:45:52Z","timestamp":1272030352000},"page":"963-972","source":"Crossref","is-referenced-by-count":6,"title":["Kopfschmerz und Bluthochdruck","Headache and hypertension"],"prefix":"10.1007","volume":"81","author":[{"given":"T.","family":"Liman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Siebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,4,25]]},"reference":[{"key":"2996_CR1","doi-asserted-by":"crossref","unstructured":"Chatellier G et al (1982) Symptom prevalence in hypertensive patients. Eur Heart J 3[Suppl C]:45\u201352","DOI":"10.1093\/eurheartj\/3.suppl_C.45"},{"key":"2996_CR2","unstructured":"Di Tullio M et al (1988) Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA). J Hypertens [Suppl 6](1):87\u201390"},{"key":"2996_CR3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1526-4610.1985.hed2503136.x","volume":"25","author":"Featherstone","year":"1985","unstructured":"Featherstone HJ (1985) Medical diagnoses and problems in individuals with recurrent idiopathic headaches. Headache 25(3):136\u2013140","journal-title":"Headache"},{"key":"2996_CR4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1962.03050170033006","volume":"180","author":"Moser","year":"1962","unstructured":"Moser M, Wish H, Friedman AP (1962) Headache and hypertension. JAMA 180:301\u2013306","journal-title":"JAMA"},{"key":"2996_CR5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(53)92410-6","volume":"1","author":"Stewart","year":"1953","unstructured":"Stewart IM (1953) Headache and hypertension. Lancet 1(6774):1261\u20131266","journal-title":"Lancet"},{"key":"2996_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.1.5741.142","volume":"1","author":"Waters","year":"1971","unstructured":"Waters WE (1971) Headache and blood pressure in the community. Br Med J 1(5741):142\u2013143","journal-title":"Br Med J"},{"key":"2996_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJM197209282871303","volume":"287","author":"Weiss","year":"1972","unstructured":"Weiss NS (1972) Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The united states health examination survey of adults. N Engl J Med 287(13):631\u2013633","journal-title":"N Engl J Med"},{"key":"2996_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1526-4610.1978.hed1802080.x","volume":"18","author":"Schele","year":"1978","unstructured":"Schele R, Ahlborg B, Ekbom K (1978) Physical characteristics and allergic history in young men with migraine and other headaches. Headache 18(2):80\u201386","journal-title":"Headache"},{"key":"2996_CR9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ije\/8.4.355","volume":"8","author":"Kottke","year":"1979","unstructured":"Kottke TE et al (1979) The relationship of symptoms and blood pressure in a population sample. Int J Epidemiol 8(4):355\u2013359","journal-title":"Int J Epidemiol"},{"key":"2996_CR10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1526-4610.1985.hed2503147.x","volume":"25","author":"Paulin","year":"1985","unstructured":"Paulin JM et al (1985) The prevalence of headache in a small New Zealand town. Headache 25(3):147\u2013151","journal-title":"Headache"},{"key":"2996_CR11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archneur.1987.00520220030011","volume":"44","author":"Chen","year":"1987","unstructured":"Chen TC et al (1987) Migraine and other diseases in women of reproductive age. The influence of smoking on observed associations. Arch Neurol 44(10):1024\u20131028","journal-title":"Arch Neurol"},{"key":"2996_CR12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1212\/WNL.42.6.1225","volume":"42","author":"Rasmussen","year":"1992","unstructured":"Rasmussen BK, Olesen J (1992) Symptomatic and nonsymptomatic headaches in a general population. Neurology 42(6):1225\u20131231","journal-title":"Neurology"},{"key":"2996_CR13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1526-4610.2001.111006164.x","volume":"41","author":"Ho","year":"2001","unstructured":"Ho KH, Benjamin KC (2001) Perceived headache associations in Singapore: results of a randomized national survey. Headache 41(2):164\u2013170","journal-title":"Headache"},{"key":"2996_CR14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archinte.161.2.252","volume":"161","author":"Gus","year":"2001","unstructured":"Gus M et al (2001) Behavior of ambulatory blood pressure surrounding episodes of headache in mildly hypertensive patients. Arch Intern Med 161(2):252\u2013255","journal-title":"Arch Intern Med"},{"key":"2996_CR15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004872-200018040-00013","volume":"18","author":"Kruszewski","year":"2000","unstructured":"Kruszewski P et al (2000) Headache in patients with mild to moderate hypertension is generally not associated with simultaneous blood pressure elevation. J Hypertens 18(4):437\u2013444","journal-title":"J Hypertens"},{"key":"2996_CR16","unstructured":"IHS (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache classification committee of the international headache society. Cephalalgia 8[Suppl 7]:1\u201396"},{"key":"2996_CR17","unstructured":"IHS (2004) The international classification of headache disorders: 2nd edn. Cephalalgia 24[Suppl 1]:9\u2013160"},{"key":"2996_CR18","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","volume":"157","author":"JNC","year":"1997","unstructured":"JNC (1997) The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157(21):2413\u20132446","journal-title":"Arch Intern Med"},{"key":"2996_CR19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.jhh.1001621","volume":"17","author":"Fuchs","year":"2003","unstructured":"Fuchs FD et al (2003) Headache is not more frequent among patients with moderate to severe hypertension. J Hum Hypertens 17(11):787\u2013790","journal-title":"J Hum Hypertens"},{"key":"2996_CR20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/archinte.1913.00070060147012","volume":"12","author":"Janeway","year":"1913","unstructured":"Janeway T (1913) A clinical study of hypertensive cardiovascular disease. Arch Intern Med 12:755\u2013798","journal-title":"Arch Intern Med"},{"key":"2996_CR21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.38.2.121","volume":"38","author":"Bulpitt","year":"1976","unstructured":"Bulpitt CJ, Dollery CT, Carne S (1976) Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 38(2):121\u2013128","journal-title":"Br Heart J"},{"key":"2996_CR22","first-page":"41","volume":"3","author":"Cooper","year":"1989","unstructured":"Cooper WD et al (1989) Headache and blood pressure: evidence of a close relationship. J Hum Hypertens 3(1):41\u201344","journal-title":"J Hum Hypertens"},{"key":"2996_CR23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2165\/00002018-199614020-00005","volume":"14","author":"Brater","year":"1996","unstructured":"Brater DC (1996) Benefits and risks of torasemide in congestive heart failure and essential hypertension. Drug Saf 14(2):104\u2013120","journal-title":"Drug Saf"},{"key":"2996_CR24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00003495-199855060-00018","volume":"55","author":"Brogden","year":"1998","unstructured":"Brogden RN, Wiseman LR (1998) Moexipril. A review of its use in the management of essential hypertension. Drugs 55(6):845\u2013860","journal-title":"Drugs"},{"key":"2996_CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2165\/00003495-199448020-00010","volume":"48","author":"Lee","year":"1994","unstructured":"Lee CR, Bryson HM (1994) Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 48(2):274\u2013296","journal-title":"Drugs"},{"key":"2996_CR26","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/archinte.160.11.1654","volume":"160","author":"Hansson","year":"2000","unstructured":"Hansson L et al (2000) Headache in mild-to-moderate hypertension and its reduction by irbesartan therapy. Arch Intern Med 160(11):1654\u20131658","journal-title":"Arch Intern Med"},{"key":"2996_CR27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1468-2982.2002.00340.x","volume":"22","author":"Bensenor","year":"2002","unstructured":"Bensenor IJ et al (2002) Blood pressure behaviour in chronic daily headache. Cephalalgia 22(3):190\u2013194","journal-title":"Cephalalgia"},{"key":"2996_CR28","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00004872-200207000-00016","volume":"20","author":"Wiehe","year":"2002","unstructured":"Wiehe M et al (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20(7):1303\u20131306","journal-title":"J Hypertens"},{"key":"2996_CR29","first-page":"463","volume":"72","author":"Hagen","year":"2002","unstructured":"Hagen K et al (2002) Blood pressure and risk of headache: a prospective study of 22 685 adults in Norway. J Neurol Neurosurg Psychiatry 72(4):463\u2013466","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2996_CR30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0404.2005.00476.x","volume":"112","author":"Pietrini","year":"2005","unstructured":"Pietrini U, De Luca M, De Santis G (2005) Hypertension in headache patients? A clinical study. Acta Neurol Scand 112(4):259\u2013264","journal-title":"Acta Neurol Scand"},{"key":"2996_CR31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"Duley","year":"2009","unstructured":"Duley L (2009) The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33(3):130\u2013137","journal-title":"Semin Perinatol"},{"key":"2996_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(00)02539-3","volume":"356","author":"Vaughan","year":"2000","unstructured":"Vaughan CJ, Delanty N (2000) Hypertensive emergencies. Lancet 356(9227):411\u2013417","journal-title":"Lancet"},{"key":"2996_CR33","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(65)91257-2","volume":"1","author":"Blackwell","year":"1965","unstructured":"Blackwell B, Mabbitt LA (1965) Tyramine in cheese related to hypertensive crises after monoamine-oxidase inhibition. Lancet 1(7392):938\u2013940","journal-title":"Lancet"},{"key":"2996_CR34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0140-6736(88)91353-0","volume":"1","author":"Littlewood","year":"1988","unstructured":"Littlewood JT et al (1988) Red wine as a cause of migraine. Lancet 1(8585):558\u2013559","journal-title":"Lancet"},{"key":"2996_CR35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archinte.1928.00130140126010","volume":"41","author":"Oppenheimer","year":"1928","unstructured":"Oppenheimer BS, Fishberg AM (1928) Hypertensive encephalopathy. Arch Intern Med 41(2):264\u2013278","journal-title":"Arch Intern Med"},{"key":"2996_CR36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00127893-200201000-00003","volume":"8","author":"Schwartz","year":"2002","unstructured":"Schwartz RB (2002) Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist 8(1):22\u201334","journal-title":"Neurologist"},{"key":"2996_CR37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jocn.2005.03.042","volume":"13","author":"Mirza","year":"2006","unstructured":"Mirza A (2006) Posterior reversible encephalopathy syndrome: a variant of hypertensive encephalopathy. J Clin Neurosci 13(5):590\u2013595","journal-title":"J Clin Neurosci"},{"key":"2996_CR38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/088307389901400502","volume":"14","author":"Pavlakis","year":"1999","unstructured":"Pavlakis SG, Frank Y, Chusid R (1999) Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 14(5):277\u2013281","journal-title":"J Child Neurol"},{"key":"2996_CR39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3174\/ajnr.A0929","volume":"29","author":"Bartynski","year":"2008","unstructured":"Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29(6):1043\u20131049","journal-title":"AJNR Am J Neuroradiol"},{"key":"2996_CR40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000092434","volume":"21","author":"Aaslid","year":"2006","unstructured":"Aaslid R (2006) Cerebral autoregulation and vasomotor reactivity. Front Neurol Neurosci 21:216\u2013228","journal-title":"Front Neurol Neurosci"},{"key":"2996_CR41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(54)91821-8","volume":"267","author":"Byrom","year":"1954","unstructured":"Byrom FB (1954) The pathogenesis of hypertensive encephalopathy and its relation to the malignant phase of hypertension; experimental evidence from the hypertensive rat. Lancet 267(6831):201\u2013211","journal-title":"Lancet"},{"key":"2996_CR42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000117195","volume":"36","author":"Sheth","year":"1996","unstructured":"Sheth RD et al (1996) Parietal occipital edema in hypertensive encephalopathy: a pathogenic mechanism. Eur Neurol 36(1):25\u201328","journal-title":"Eur Neurol"},{"key":"2996_CR43","first-page":"69","volume":"1978","author":"Edvinsson","year":"1978","unstructured":"Edvinsson L, Hardebo JE, Owman C (1978) Influence of the cerebrovascular sympathetic innervation on regional flow, autoregulation, and blood-brain barrier function. Ciba Found Symp 1978(56):69\u201395","journal-title":"Ciba Found Symp"},{"key":"2996_CR44","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/01.CIR.0000031798.07790.FE","volume":"106","author":"Zhang","year":"2002","unstructured":"Zhang R et al (2002) Autonomic neural control of dynamic cerebral autoregulation in humans. Circulation 106(14):1814\u20131820","journal-title":"Circulation"},{"key":"2996_CR45","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1291\/hypres.25.797","volume":"25","author":"Kumai","year":"2002","unstructured":"Kumai Y et al (2002) Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res 25(5):797\u2013800","journal-title":"Hypertens Res"},{"key":"2996_CR46","first-page":"1199","volume":"21","author":"Casey","year":"2000","unstructured":"Casey SO et al (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21(7):1199\u20131206","journal-title":"AJNR Am J Neuroradiol"},{"key":"2996_CR47","first-page":"1038","volume":"23","author":"Covarrubias","year":"2002","unstructured":"Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 23(6):1038\u20131048","journal-title":"AJNR Am J Neuroradiol"},{"key":"2996_CR48","first-page":"859","volume":"19","author":"Schwartz","year":"1998","unstructured":"Schwartz RB et al (1998) Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. AJNR Am J Neuroradiol 19(5):859\u2013862","journal-title":"AJNR Am J Neuroradiol"},{"key":"2996_CR49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.STR.26.3.488","volume":"26","author":"Ille","year":"1995","unstructured":"Ille O et al (1995) Hypertensive encephalopathy after bilateral carotid endarterectomy. Stroke 26(3):488\u2013491","journal-title":"Stroke"},{"key":"2996_CR50","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"Hinchey","year":"1996","unstructured":"Hinchey J et al (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8):494\u2013500","journal-title":"N Engl J Med"},{"key":"2996_CR51","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","volume":"29","author":"Bartynski","year":"2008","unstructured":"Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29(6):1036\u20131042","journal-title":"AJNR Am J Neuroradiol"},{"key":"2996_CR52","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(03)13177-7","volume":"361","author":"Savvidou","year":"2003","unstructured":"Savvidou MD et al (2003) Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 361(9368):1511\u20131517","journal-title":"Lancet"},{"key":"2996_CR53","first-page":"247","volume":"23","author":"Nuver","year":"2010","unstructured":"Nuver J et al (2010) Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. Oncol Rep 23(1):247\u2013253","journal-title":"Oncol Rep"},{"key":"2996_CR54","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00007890-199211000-00002","volume":"54","author":"Benigni","year":"1992","unstructured":"Benigni A et al (1992) The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 54(5):775\u2013780","journal-title":"Transplantation"},{"key":"2996_CR55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0961203307080224","volume":"16","author":"Der","year":"2007","unstructured":"Der H et al (2007) Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16(7):497\u2013503","journal-title":"Lupus"},{"key":"2996_CR56","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3174\/ajnr.A0839","volume":"29","author":"Bartynski","year":"2008","unstructured":"Bartynski WS, Boardman JF (2008) Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 29(3):447\u2013455","journal-title":"AJNR Am J Neuroradiol"},{"key":"2996_CR57","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/brain\/awm256","volume":"130","author":"Ducros","year":"2007","unstructured":"Ducros A et al (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130(12):3091\u20133101","journal-title":"Brain"},{"key":"2996_CR58","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1161\/01.HYP.27.1.144","volume":"27","author":"Zampaglione","year":"1996","unstructured":"Zampaglione B et al (1996) Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 27(1):144\u2013147","journal-title":"Hypertension"},{"key":"2996_CR59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1212\/01.WNL.0000042095.49520.1E","volume":"60","author":"Henderson","year":"2003","unstructured":"Henderson RD et al (2003) Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm. Neurology 60(2):326\u2013328","journal-title":"Neurology"},{"key":"2996_CR60","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2214\/AJR.07.2024","volume":"189","author":"McKinney","year":"2007","unstructured":"McKinney AM et al (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189(4):904\u2013912","journal-title":"AJR Am J Roentgenol"},{"key":"2996_CR61","first-page":"205","volume":"65","author":"Lee","year":"2008","unstructured":"Lee VH et al (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65(2):205\u2013210","journal-title":"Arch Neurol"},{"key":"2996_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00042737-199805000-00015","volume":"10","author":"Idilman","year":"1998","unstructured":"Idilman R et al (1998) Immunosuppressive drug-induced leukoencephalopathy in patients with liver transplant. Eur J Gastroenterol Hepatol 10(5):433\u2013436","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2996_CR63","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1016\/S0272-6386(01)90016-2","volume":"37","author":"Ikeda","year":"2001","unstructured":"Ikeda M et al (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37(4):E30","journal-title":"Am J Kidney Dis"},{"key":"2996_CR64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000045931","volume":"87","author":"Kim","year":"2001","unstructured":"Kim BS et al (2001) Posterior leukoencephalopathy syndrome during steroid therapy in a down syndrome patient with nephrotic syndrome. Nephron 87(3):289\u2013290","journal-title":"Nephron"},{"key":"2996_CR65","first-page":"949","volume":"42","author":"Kawano","year":"2002","unstructured":"Kawano H et al (2002) [Reversible posterior leukoencephalopathy syndrome in two patients with microscopic polyarteritis nodosa]. Rinsho Shinkeigaku 42(10):949\u2013953","journal-title":"Rinsho Shinkeigaku"},{"key":"2996_CR66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s101570300009","volume":"7","author":"Utsumi","year":"2003","unstructured":"Utsumi K et al (2003) Acute posterior leukoencephalopathy in a patient with nephrotic syndrome. Clin Exp Nephrol 7(1):63\u201366","journal-title":"Clin Exp Nephrol"},{"key":"2996_CR67","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00467-003-1286-y","volume":"19","author":"Ohta","year":"2004","unstructured":"Ohta T et al (2004) Reversible posterior leukoencephalopathy in a patient with Wegener granulomatosis. Pediatr Nephrol 19(4):442\u2013444","journal-title":"Pediatr Nephrol"},{"key":"2996_CR68","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1200\/JCO.2007.10.9991","volume":"25","author":"Irvin","year":"2007","unstructured":"Irvin W et al (2007) Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol 25(17):2484\u20132486","journal-title":"J Clin Oncol"},{"key":"2996_CR69","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jnnp.69.5.704","volume":"69","author":"Lewis","year":"2000","unstructured":"Lewis M, Maddison P (2000) Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome? J Neurol Neurosurg Psychiatry 69(5):704","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2996_CR70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2169\/internalmedicine.38.54","volume":"38","author":"Tajima","year":"1999","unstructured":"Tajima Y et al (1999) Two similar cases of encephalopathy, possibly a reversible posterior leukoencephalopathy syndrome: serial findings of magnetic resonance imaging, SPECT and angiography. Intern Med 38(1):54\u201358","journal-title":"Intern Med"},{"key":"2996_CR71","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1016\/S0272-6386(01)90015-0","volume":"37","author":"Kamar","year":"2001","unstructured":"Kamar N et al (2001) Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients. Am J Kidney Dis 37(4): E29","journal-title":"Am J Kidney Dis"},{"key":"2996_CR72","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archneur.64.5.746","volume":"64","author":"Nagel","year":"2007","unstructured":"Nagel S et al (2007) Linezolid-induced posterior reversible leukoencephalopathy syndrome. Arch Neurol 64(5):746\u2013748","journal-title":"Arch Neurol"},{"key":"2996_CR73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0895-7061(02)02264-1","volume":"15","author":"Giner","year":"2002","unstructured":"Giner V et al (2002) Reversible posterior leukoencephalopathy secondary to indinavir-induced hypertensive crisis: a case report. Am J Hypertens 15(5):465\u2013467","journal-title":"Am J Hypertens"},{"key":"2996_CR74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1341-8076.2002.00018.x","volume":"28","author":"Sueblinvong","year":"2002","unstructured":"Sueblinvong T et al (2002) Posterior leukoencephalopathy following cisplatin, bleomycin and vinblastine therapy for germ cell tumor of the ovary. J Obstet Gynaecol Res 28(2):99\u2013103","journal-title":"J Obstet Gynaecol Res"},{"key":"2996_CR75","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.transproceed.2009.01.041","volume":"41","author":"Dzudie","year":"2009","unstructured":"Dzudie A et al (2009) Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports. Transplant Proc 41(2):716\u2013720","journal-title":"Transplant Proc"},{"key":"2996_CR76","unstructured":"Nishigaki Y et al (1999) [Reversible posterior leukoencephalopathy in a patient receiving cyclosporin therapy]. Rinsho Shinkeigaku 39(2\u20133):360\u2013363"},{"key":"2996_CR77","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00115-006-2055-5","volume":"77","author":"Paul","year":"2006","unstructured":"Paul F et al (2006) [Relapsing reversible posterior leukoencephalopathy after chemotherapy with cisplatin and 5-fluorouracil]. Nervenarzt 77(6):706\u2013710","journal-title":"Nervenarzt"},{"key":"2996_CR78","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/ndt\/14.10.2489","volume":"14","author":"Grimbert","year":"1999","unstructured":"Grimbert P et al (1999) Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant 14(10):2489\u20132491","journal-title":"Nephrol Dial Transplant"},{"key":"2996_CR79","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2169\/internalmedicine.42.624","volume":"42","author":"Nakazato","year":"2003","unstructured":"Nakazato T et al (2003) Reversible posterior leukoencephalopathy syndrome associated with tacrolimus therapy. Intern Med 42(7):624\u2013625","journal-title":"Intern Med"},{"key":"2996_CR80","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12028-008-9096-5","volume":"9","author":"Legriel","year":"2008","unstructured":"Legriel S et al (2008) Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus. Neurocrit Care 9(2):247\u2013252","journal-title":"Neurocrit Care"},{"key":"2996_CR81","first-page":"305","volume":"21","author":"Rodriguez","year":"2001","unstructured":"Rodriguez Gomez E et al (2001) [Reversible posterior leukoencephalopathy, severe hypertension, and cocaine abuse]. Nefrologia 21(3):305\u2013308","journal-title":"Nefrologia"},{"key":"2996_CR82","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s002340000482","volume":"42","author":"Honkaniemi","year":"2000","unstructured":"Honkaniemi J et al (2000) Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 42(12):895\u2013899","journal-title":"Neuroradiology"},{"key":"2996_CR83","first-page":"415","volume":"19","author":"Ito","year":"1998","unstructured":"Ito Y et al (1998) Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR 19(3):415\u2013417","journal-title":"AJNR"},{"key":"2996_CR84","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1212\/01.wnl.0000264428.76387.87","volume":"68","author":"Bodkin","year":"2007","unstructured":"Bodkin CL, Eidelman BH (2007) Sirolimus-induced posterior reversible encephalopathy. Neurology 68(23):2039\u20132040","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2996-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-010-2996-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-010-2996-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:08:45Z","timestamp":1558573725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-010-2996-6"}},"subtitle":["Mythos und Evidenz","Myth and evidence"],"short-title":[],"issued":{"date-parts":[[2010,4,25]]},"references-count":84,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["2996"],"URL":"https:\/\/doi.org\/10.1007\/s00115-010-2996-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,25]]}}}